Gallacher Capital Management LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Gallacher Capital Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 20.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,216 shares of the healthcare conglomerate’s stock after buying an additional 205 shares during the quarter. Gallacher Capital Management LLC’s holdings in UnitedHealth Group were worth $640,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Valley Brook Capital Group Inc. boosted its holdings in UnitedHealth Group by 0.5% in the fourth quarter. Valley Brook Capital Group Inc. now owns 6,671 shares of the healthcare conglomerate’s stock worth $3,512,000 after purchasing an additional 30 shares during the last quarter. W.H. Cornerstone Investments Inc. raised its position in shares of UnitedHealth Group by 1.8% during the fourth quarter. W.H. Cornerstone Investments Inc. now owns 1,604 shares of the healthcare conglomerate’s stock valued at $845,000 after buying an additional 28 shares during the last quarter. Evergreen Wealth Management LLC grew its position in shares of UnitedHealth Group by 1.8% during the fourth quarter. Evergreen Wealth Management LLC now owns 2,032 shares of the healthcare conglomerate’s stock valued at $1,070,000 after purchasing an additional 35 shares in the last quarter. Clearstead Trust LLC boosted its stake in UnitedHealth Group by 17.2% during the fourth quarter. Clearstead Trust LLC now owns 12,695 shares of the healthcare conglomerate’s stock valued at $6,683,000 after buying an additional 1,861 shares during the last quarter. Finally, SYM FINANCIAL Corp boosted its position in shares of UnitedHealth Group by 30.1% during the fourth quarter. SYM FINANCIAL Corp now owns 579 shares of the healthcare conglomerate’s stock valued at $305,000 after buying an additional 134 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

UNH has been the subject of several research reports. Piper Sandler upped their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research report on Thursday, April 4th. Barclays lifted their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Stephens restated an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Finally, Bank of America reissued a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Stock Down 0.1 %

UNH traded down $0.52 on Friday, hitting $492.45. 2,487,811 shares of the company were exchanged, compared to its average volume of 5,130,659. The firm has a 50-day moving average price of $482.32 and a two-hundred day moving average price of $512.42. The company has a market cap of $453.09 billion, a price-to-earnings ratio of 30.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the company posted $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.